META
Meta Platforms, Inc.
META's fundamentals are mixed, but it looks cheap: trading at 21x earnings, below its usual 27x. Analysts expect earnings growth, though they disagree widely on how much.
SLE
Super League Enterprise, Inc.
There isn't enough reported data to score SLE yet.
META Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
META's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
SLE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Unavailable | |
| Unavailable |
SLE's revenue is currently stable, but its profitability is weak. There isn't enough data to rate its cash flow and balance sheet.
META PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $624 | — |
| Cheap | 21x | $613 | -1.7% |
| Current | 21x | $624 | — |
| Fair | 27x | $803 | +29% |
| Expensive | 32x | $934 | +50% |
Historical ranges are pointers, not guarantees.
META's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 19x next year's earnings.
SLE PE Valuation
SLE has no meaningful PE right now: it lost money over the past year.
META Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for META, but weaker profitability. However, they disagree widely on these estimates.
SLE Forward outlook
There aren't enough analyst estimates for SLE to show an outlook.
META Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $32.16 | +9.7% |
| Q3 2026 | $29.32 | +30% |
| Q2 2026 | $26.54 | -3.7% |
| Q1 2026 | $27.50 | +7.5% |
| Q4 2025 | $23.49 | -1.6% |
| Q3 2025 | $22.58 | +6.5% |
| Q2 2025 | $27.56 | +41% |
| Q1 2025 | $25.58 | +47% |
| Q4 2024 | $23.86 | +60% |
META has the edge over SLE on earnings quality, reporting a profit while its opponent remains loss making.
SLE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$161.95 | +$372.29 |
| Q1 2026 | -$213.49 | +$554.51 |
| Q4 2025 | -$331.72 | +$796.28 |
| Q3 2023 | -$8,164.80 | +$11,515.20 |
| Q2 2023 | -$21,216.00 | -$13,152.00 |
| Q1 2023 | -$21,888.00 | -$15,456.00 |
| Q4 2022 | -$22,080.00 | -$15,456.00 |
| Q3 2022 | -$19,680.00 | -$12,960.00 |
SLE lost $161.95 per share over the past year, a smaller loss than the year before.
META Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.6B | +26% |
| Q2 2026 | $60.8B | +28% |
| Q1 2026 | $56.3B | +33% |
| Q4 2025 | $59.9B | +24% |
| Q3 2025 | $51.2B | +26% |
| Q2 2025 | $47.5B | +22% |
| Q1 2025 | $42.3B | +16% |
| Q4 2024 | $48.4B | +21% |
META has the edge over SLE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -20 points |
| Q2 2026 | 31% | -12 points |
| Q1 2026 | 41% | -0.9 points |
| Q4 2025 | 41% | -7 points |
| Q3 2025 | 40% | -2.7 points |
| Q2 2025 | 43% | +5 points |
| Q1 2025 | 41% | +3.6 points |
| Q4 2024 | 48% | +7.4 points |
META has the edge over SLE on profitability, with a higher operating margin.
SLE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $3M | +0.3% |
| Q1 2026 | $3M | +10% |
| Q4 2025 | $3.2M | -6.6% |
| Q3 2025 | $2.4M | -45% |
| Q2 2025 | $3M | -27% |
| Q1 2025 | $2.7M | -35% |
| Q4 2024 | $3.4M | -64% |
| Q3 2024 | $4.4M | -38% |
SLE's revenue has slid since its 2023 peak: $3M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -121% | -16 points |
| Q1 2026 | -138% | -4.9 points |
| Q4 2025 | -101% | +34 points |
| Q3 2025 | -126% | -48 points |
| Q2 2025 | -105% | -5.4 points |
| Q1 2025 | -134% | -24 points |
| Q4 2024 | -134% | +1.7 points |
| Q3 2024 | -78% | -15 points |
SLE's operating margin was −121% last quarter, down 16 points from the same quarter a year ago.
META Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -110% |
| Q2 2026 | $1.7B | -81% |
| Q1 2026 | $13.2B | +19% |
| Q4 2025 | $14.8B | +9.3% |
| Q3 2025 | $11.2B | -32% |
| Q2 2025 | $9B | -19% |
| Q1 2025 | $11.1B | -14% |
| Q4 2024 | $13.6B | +16% |
SLE has the stronger cash trend. Its trailing FCF is up 35% versus its history, compared with META at down 24%.
SLE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.2M | -$409K |
| Q1 2026 | -$2.5M | -$320K |
| Q4 2025 | -$3.9M | -$565K |
| Q2 2025 | -$1.8M | +$517K |
| Q1 2025 | -$2.2M | +$1.5M |
| Q4 2024 | -$3.3M | -$1.9M |
| Q3 2024 | -$2.1M | +$1.2M |
| Q2 2024 | -$2.3M | +$5.5M |
SLE has burned cash in almost every quarter: −$10M over the past year, against −$10M the year before.
META Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +7M shares |
| 1 year | 0% | +1M shares |
| 3 years | -2.6% | -68M shares |
| 5 years | -10% | -286M shares |
| Available history | -11% | -303M shares |
META has the edge over SLE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $3.3B |
| Q2 2025 | $10.2B |
| Q1 2025 | $12.8B |
| Q4 2024 | — |
META hasn't bought back shares in the past year.
SLE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -24% | -592K shares |
| 1 year | +4693% | +1.8M shares |
| 3 years | +46695% | +1.8M shares |
| 5 years | +146463% | +1.8M shares |
| Available history | +206205% | +1.8M shares |
SLE has 2M diluted shares, up 4693% from a year ago.
META Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.2x | Net Cash |
META's net debt is less than a year of its operating earnings (EBITDA).
SLE Net Leverage
SLE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
META Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.2 | Neutral |
| Stochastic | 33.7 | Neutral |
META's weekly RSI is 48 (neutral) and its Stochastic is 34 (neutral).
SLE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 40.7 | Neutral |
SLE's weekly RSI is 42 (neutral) and its Stochastic is 41 (neutral).
META PE vs Communication Services Sector
| Metric | META | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 16x | 29% above |
| PE % | 18 | 26 | 8 pts below |
META is trading at 21x earnings, a 29% premium to the Communication Services sector's median of 16x.
SLE PE vs Communication Services Sector
SLE has no meaningful PE right now: it lost money over the past year.
META Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $674.9 | 7.6% below |
| 20 week MA | $634.5 | 1.7% below |
| 50 week MA | $630.8 | 1.1% below |
| 100 week MA | $647.8 | 3.7% below |
| 200 week MA | $517.5 | 21% above |
META has the edge over SLE on trend strength, trading above more of its moving averages.
SLE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.80 | 17% below |
| 20 week MA | $3.99 | 0.5% below |
| 50 week MA | $4.68 | 15% below |
| 100 week MA | $60.6 | 93% below |
| 200 week MA | $1,011.6 | 100% below |
SLE is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
META Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $208.1 | $267.4 | +28% |
| 2021 | $267.4 | $335.2 | +25% |
| 2022 | $335.2 | $118.0 | -65% |
| 2023 | $118.0 | $354.0 | +200% |
| 2024 | $354.0 | $599.8 | +69% |
| 2025 | $599.8 | $663.3 | +11% |
| 2026 YTD | $663.3 | $623.6 | -6% |
META has the edge over SLE on returns for 2026, with the stronger performance.
SLE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23,520.0 | $33,120.0 | +41% |
| 2021 | $33,120.0 | $24,288.0 | -27% |
| 2022 | $24,288.0 | $3,379.2 | -86% |
| 2023 | $3,379.2 | $729.6 | -78% |
| 2024 | $729.6 | $316.3 | -57% |
| 2025 | $316.3 | $7.26 | -98% |
| 2026 YTD | $7.26 | $3.97 | -45% |
SLE has finished five years in a row lower, and it's down 45% so far in 2026.